Showing results (911-920 of 1,030) with videos related to
Sort By:
Pageof 103
Cancer|May 21, 2014
Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle studyNienke A de Glas, Duveken B Y Fontein, Esther Bastiaannet, et al.Journal of Virology|October 11, 2023
The neuraminidase activity of influenza A virus determines the strain-specific sensitivity to neutralization by respiratory mucusAlena N Iseli, Marie O Pohl, Irina Glas, et al.JAMA|April 22, 2004
Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trialJohn D Puskas, Willis H Williams, Elizabeth M Mahoney, et al.Stem Cells (Dayton, Ohio)|February 8, 2013
Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastomaMartin Glas, Christoph Coch, Daniel Trageser, et al.International Journal of Molecular Medicine|November 3, 2010
Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancerHeidrun Gevensleben, Uwe-Jochen Göhring, Reinhard Büttner, et al.Breast Cancer Research : BCR|June 19, 2023
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancerM C Liefaard, A van der Voort, M S van Ramshorst, et al.Neuro-Oncology Practice|May 14, 2026
End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische ArbeitsgemeinschaftLazaros Lazaridis, Niklas Benedikt Pepper, Paula Klein, et al.Communications Biology|July 29, 2020
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trialLaurent Jacob, Anke Witteveen, Inès Beumer, et al.Aging Cell|April 17, 2025
Targeting ATF6α Attenuates UVB-Induced Senescence and Improves Skin Homeostasis by Regulating IL8 ExpressionJoëlle Giroud, Pauline Delvaux, Laura Carlier, et al.Journal of the National Cancer Institute|September 7, 2006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancerMarc Buyse, Sherene Loi, Laura van't Veer, et al.Pageof 103